InspireMD Files 8-K on Financials
Ticker: NSPR · Form: 8-K · Filed: May 9, 2025 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
InspireMD dropped an 8-K on May 9th detailing their financial results. Check it out.
AI Summary
InspireMD, Inc. filed an 8-K on May 9, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Tel Aviv, Israel.
Why It Matters
This 8-K filing provides an update on InspireMD's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- May 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Tel Aviv, Israel (location) — Address of Principal Executive Offices
- Saguaro Resources, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for InspireMD, Inc.?
The primary purpose of this 8-K filing is to report on InspireMD, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on May 9, 2025.
Where are InspireMD, Inc.'s principal executive offices located?
InspireMD, Inc.'s principal executive offices are located at 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832.
What was InspireMD, Inc.'s former company name?
InspireMD, Inc.'s former company name was Saguaro Resources, Inc.
In which U.S. state was InspireMD, Inc. incorporated?
InspireMD, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding InspireMD, Inc. (NSPR).